Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

To determine the level of agreement of disease flare severity (distinguishing severe, moderate, and mild flare and persistent disease activity) in a large paper‐patient exercise involving 988 individual cases of systemic lupus erythematosus.

[1]  A. Orbai,et al.  Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary , 2015, The Journal of Rheumatology.

[2]  E. Chakravarty,et al.  How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index. , 2014, Rheumatology.

[3]  C. Gordon,et al.  Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial) , 2014, Annals of the rheumatic diseases.

[4]  D. Isenberg,et al.  Assessment of disease activity, damage and quality of life in systemic lupus erythematosus: new aspects. , 2013, Best practice & research. Clinical rheumatology.

[5]  M. Petri,et al.  A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[6]  Gerald McGwin,et al.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[7]  M. Urowitz,et al.  International consensus for a definition of disease flare in lupus , 2011, Lupus.

[8]  I. Bruce,et al.  An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA , 2010, Annals of the rheumatic diseases.

[9]  I. Bruce,et al.  Numerical scoring for the BILAG-2004 index , 2010, Rheumatology.

[10]  I. Bruce,et al.  The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients , 2010, Rheumatology.

[11]  I. Bruce,et al.  The BILAG-2004 index is sensitive to change for assessment of SLE disease activity , 2009, Rheumatology.

[12]  Mimi Y. Kim,et al.  Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[13]  C. Gordon,et al.  Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group. , 2004, The Journal of rheumatology.

[14]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[15]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[16]  C. Gordon,et al.  Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. , 2010, Arthritis and rheumatism.